Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Price Over Earnings Overview: Biogen
March 31, 2023
Tickers
BIIB
Tags
Benzinga
Market News
Markets
From
Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
March 31, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
Health Care
News
From
Benzinga
Biogen Unusual Options Activity
March 23, 2023
Tickers
BIIB
Tags
Markets
Options
Benzinga
From
Benzinga
11 Analysts Have This to Say About Biogen
March 23, 2023
Tickers
BIIB
Tags
BZI/AAR
BIIB
Analyst Ratings
From
Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
Tickers
BIIB
BNTX
GIB
MRNA
Tags
MRNA
QCOM
Stocks to Buy
From
InvestorPlace
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
News
Health Care
BIIB
From
Benzinga
iMetabolic BioPharma's Alzheimer's Disease Therapeutic Innovation Is A Breakthrough Three-Pronged Approach
March 22, 2023
Tickers
BIIB
Tags
Biotech
Partner Content
General
From
Benzinga
Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?
March 22, 2023
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
Tickers
BIIB
ESALY
HRMY
INCY
Tags
BIIB
LLY
INSP
From
InvestorPlace
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
JP:4523
AMLX
IONS
From
MarketWatch
Despite Failed Phase 3 Study, FDA Staff Says Biogen's ALS Drug May Have Clinical Benefit
March 21, 2023
Tickers
BIIB
Tags
News
BIIB
Health Care
From
Benzinga
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
March 20, 2023
Tickers
BIIB
NVS
SGMO
Tags
SGMO
Trading Ideas
NVS
From
Benzinga
Should You Buy Biogen Before a Big July Decision?
March 19, 2023
Tickers
BIIB
Tags
BIIB
Recent Press Releases
ESAI/Y
From
Motley Fool
Price Over Earnings Overview: Biogen
March 17, 2023
Tickers
BIIB
Tags
Benzinga
Market News
Markets
From
Benzinga
(BIIB) - Analyzing Biogen's Short Interest
March 17, 2023
Tickers
BIIB
Tags
BIIB
Market News
Benzinga
From
Benzinga
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
Large Cap
General
Markets
From
Benzinga
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
March 16, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
BIIB
News
Health Care
From
Benzinga
Biogen's Debt Overview
March 15, 2023
Tickers
BIIB
Tags
Benzinga
Market News
BZI/Debt
From
Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
March 14, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Movers
Large Cap
General
From
Benzinga
1 Reason to Buy Biogen Stock, and 1 Reason to Sell
March 14, 2023
Tickers
BIIB
Tags
Market News
BIIB
Recent Press Releases
From
Motley Fool
Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone
March 13, 2023
Tickers
BIIB
SAGE
Tags
Briefs
Health Care
News
From
Benzinga
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
March 09, 2023
Tickers
BIIB
SAVA
Tags
NASDAQ:SAVA,NASDAQ:BIIB
SAVA
Today's Market
From
InvestorPlace
Why Shares of Anavex Life Sciences Rose 12.4% in February
March 06, 2023
Tickers
AVXL
BIIB
Tags
Market News
Recent Press Releases
ESAI/Y
From
Motley Fool
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
March 06, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
ESALY
ESALF
From
Benzinga
Medicare just crushed the hopes of 750,000 Alzheimer’s patients a year
March 03, 2023
Tickers
BIIB
SPX
Tags
SPX
BIIB
RUT
From
MarketWatch
What Does Biogen's Debt Look Like?
March 02, 2023
Tickers
BIIB
Tags
Intraday Update
BIIB
News
From
Benzinga
Peering Into Biogen's Recent Short Interest
March 01, 2023
Tickers
BIIB
Tags
Trading Ideas
Short Ideas
BZI/SHORTHIST
From
Benzinga
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
XPH
RETA
SRPT
From
MarketWatch
Why Reata Pharmaceuticals Shares Are Falling Monday?
February 27, 2023
Tickers
BIIB
RETA
Tags
Trading Ideas
FDA
WIIM
From
Benzinga
Analyst Initiates Coverage of GE Healthcare, Says' Path To Greatness Well-Paved'
February 17, 2023
Tickers
BIIB
GE
GEHC
Tags
Trading Ideas
Analyst Ratings
GE
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today